Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms.

Science
M Alejandra TortoriciDavid Veesler

Abstract

Efficient therapeutic options are needed to control the spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that has caused more than 922,000 fatalities as of 13 September 2020. We report the isolation and characterization of two ultrapotent SARS-CoV-2 human neutralizing antibodies (S2E12 and S2M11) that protect hamsters against SARS-CoV-2 challenge. Cryo-electron microscopy structures show that S2E12 and S2M11 competitively block angiotensin-converting enzyme 2 (ACE2) attachment and that S2M11 also locks the spike in a closed conformation by recognition of a quaternary epitope spanning two adjacent receptor-binding domains. Antibody cocktails that include S2M11, S2E12, or the previously identified S309 antibody broadly neutralize a panel of circulating SARS-CoV-2 isolates and activate effector functions. Our results pave the way to implement antibody cocktails for prophylaxis or therapy, circumventing or limiting the emergence of viral escape mutants.

References

Oct 1, 1990·Antiviral Research·M N Prichard, C Shipman
Apr 12, 2003·The New England Journal of Medicine·Christian DrostenHans Wilhelm Doerr
Apr 12, 2003·The New England Journal of Medicine·Thomas G KsiazekUNKNOWN SARS Working Group
Jul 21, 2004·Journal of Computational Chemistry·Eric F PettersenThomas E Ferrin
May 14, 2005·Journal of Structural Biology·Christian SulowayBridget Carragher
Aug 1, 2007·Journal of Applied Crystallography·Airlie J McCoyRandy J Read
Jan 9, 2010·Acta Crystallographica. Section D, Biological Crystallography·Vincent B ChenDavid C Richardson
Feb 4, 2010·Acta Crystallographica. Section D, Biological Crystallography·Wolfgang Kabsch
Apr 13, 2010·Acta Crystallographica. Section D, Biological Crystallography·P EmsleyK Cowtan
Oct 20, 2010·Proceedings of the National Academy of Sciences of the United States of America·Bärbel KaufmannMichael G Rossmann
Apr 5, 2011·Acta Crystallographica. Section D, Biological Crystallography·Garib N MurshudovAlexei A Vagin
Nov 20, 2015·Nature Structural & Molecular Biology·Jon AgirreKevin D Cowtan
Jan 23, 2016·Antiviral Research·Guntur Fibriansah, Shee-Mei Lok
Jan 15, 2017·Microbiology Spectrum·Stylianos BournazosJeffrey V Ravetch
Feb 7, 2017·Nature Methods·Ali PunjaniMarcus A Brubaker
Jul 16, 2017·Protein Science : a Publication of the Protein Society·Thomas D GoddardThomas E Ferrin
Aug 16, 2017·Proceedings of the National Academy of Sciences of the United States of America·Jesper PallesenJason S McLellan
Feb 27, 2018·PLoS Pathogens·Emily N GallichotteAravinda M de Silva
Oct 23, 2018·Structure·Brandon FrenzFrank DiMaio
Jan 16, 2019·Proceedings of the National Academy of Sciences of the United States of America·Feng LongMichael G Rossmann
Sep 17, 2019·Advances in Virus Research·M Alejandra Tortorici, David Veesler
Oct 8, 2019·Acta Crystallographica. Section D, Structural Biology·Dorothee LiebschnerPaul D Adams
Oct 9, 2019·Nature Methods·Dimitry Tegunov, Patrick Cramer
Jan 25, 2020·The New England Journal of Medicine·Na ZhuUNKNOWN China Novel Coronavirus Investigating and Research Team
Feb 23, 2020·Science·Daniel WrappJason S McLellan
Mar 11, 2020·Cell·Alexandra C WallsDavid Veesler
Apr 1, 2020·Nature·Jian ShangFang Li

❮ Previous
Next ❯

Citations

Dec 23, 2020·Journal of Translational Medicine·Leonardo MiscioAttilio Bianchi
Jan 14, 2021·Journal of Biomedical Science·Ioannis P TrougakosMeletios A Dimopoulos
Jan 19, 2021·Nature·Christian GaeblerMichel C Nussenzweig
Jan 5, 2021·Frontiers in Molecular Biosciences·Giuseppina MarianoJulien R C Bergeron
Feb 8, 2021·Stem Cell Research·Gangyu SunZhizhi Wang
Jan 1, 2021·Frontiers in Plant Science·Chiara LicoLinda Avesani
Nov 11, 2020·Pathogens·Jamal HussenAbdullah I A Al-Mubarak
Jan 22, 2021·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·Mikaela SmitAlexandra Calmy
Jan 23, 2021·Membranes·Jordana Muñoz-BasagoitiNuria Izquierdo-Useros
Jan 23, 2021·Advanced Drug Delivery Reviews·Saborni ChakrabortyTaia T Wang
Mar 3, 2021·Cell Reports Medicine·Michael S PiepenbrinkJames J Kobie
Feb 11, 2021·Nature·Zijun WangMichel C Nussenzweig
Mar 7, 2021·Virology·James Brett CaseMichael S Diamond
Mar 17, 2021·Wiener klinische Wochenschrift·Franz X Heinz, Karin Stiasny
Jan 1, 2021·Expert Review of Respiratory Medicine·Xingxia Yu, Rongrong Yang
Mar 12, 2021·Nature·Dami A CollierRavindra K Gupta
Apr 3, 2021·Science·Robby DivineDavid Baker
Apr 24, 2021·Microbial Cell Factories·Norma A Valdez-CruzMauricio A Trujillo-Roldán
Apr 24, 2021·Science Advances·Annachiara RosaPeter Cherepanov
Apr 25, 2021·Proceedings of the National Academy of Sciences of the United States of America·Phillip PymmWai-Hong Tham
Apr 28, 2021·EMBO Reports·Teresa R WagnerUlrich Rothbauer
May 1, 2021·The Journal of Physical Chemistry. B·Gennady M Verkhivker, Luisa Di Paola
Apr 22, 2021·MBio·Harini NatarajanMargaret E Ackerman
May 1, 2021·Nature Structural & Molecular Biology·Ha V DangDavid Veesler
Apr 28, 2021·Current Opinion in Virology·Chung-Young Lee, Anice C Lowen
May 7, 2021·The Journal of Biological Chemistry·Ian A Wilson, Robyn L Stanfield

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA
enzyme-linked immunosorbent assay
surface plasmon resonance
biolayer interferometry
biosensors
flow cytometry

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.